BioCentury
ARTICLE | Company News

Myogen, Wulfing Holding GmbH deal

February 13, 2006 8:00 AM UTC

MYOG sold its Myogen GmbH subsidiary to Wulfing. Also, MYOG granted Wulfing a sublicense to market Perfan enoximone IV outside North America. Wulfing will pay MYGO $6.1 million in cash, plus royalties...